Wantstats
Company ProfilePremium

Enzo Biochem Inc.

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
Enzo Biochem Inc. - Healthcare showcase

Year Founded & Workforce

1976

460 Employees

Industry

Healthcare

Services

Biomarkers
E

Enzo Biochem Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Enzo Biochem Inc. Overview

Company Headquarters: New York, US

Founded: 1976

Workforce: ~460

Company Working: Enzo Biochem Inc. is a life science, and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics, and therapeutics and provides reference laboratory services to the medical community. The company has significant therapeutic candidates for the treatment of viral and immunological based disorders, several of which are in various phases of human clinical trials. It operates three wholly-owned subsidiaries, namely, Enzo Life Sciences, Enzo Therapeutics, and Enzo Clinical Labs.

Strategy

Enzo Biochem Inc. is keen on developing and investing in capabilities in research and development. It also aspires to provide high value to its customers by developing advanced solutions. The company, as a part of implementing its growth strategy, has entered into an agreement to purchase a commercial facility with nearly 36,000 square feet in Farmingdale, New York, US, as in August 2018

Company Snapshot

$105.1M

Revenue

460

Employees

1976

Founded

New York, US

Headquarters

SWOT Analysis

Strengths

  • Extensive network of global integration partners
  • Increasing focus on biomedical research products and tools

Weaknesses

  • Operational failures and issues related to quality

Opportunities

  • Mergers & acquisitions and equity investments

Threats

  • Changing competitive environment

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
January 2018Product LaunchEnzo Biochem, Inc. launched a cervical cancer biomarker detection test that provides a highly robust and cost-efficient solution for anatomical pathology. With this, the company aims to strengthen its position in the global biomarkers market.

Product Offering

  • Enzo Biochem Inc.
    • Biomarkers

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales fell from USD 105.1 Mn in 2017 to USD 81.2 Mn in 2019.
Enzo Biochem Inc. — By Business Segment
Series (USD Mn)201720182019
Sales105.110181.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →